Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Cardiovasc. Med.

Sec. Cardiovascular Metabolism

Volume 12 - 2025 | doi: 10.3389/fcvm.2025.1625299

This article is part of the Research TopicThe Role of Gut Microbiome Metabolites in Cardiometabolic DisordersView all 6 articles

The Role of gut microbiota in myocardial ischemia-reperfusion injury

Provisionally accepted
Xin  ChenXin Chen1Xin  ZouXin Zou2Yuan  ZhouYuan Zhou3Chan  PengChan Peng4*Rui  HuangRui Huang1*
  • 1The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, China
  • 2The Lichuan Ethnic Hospital of Traditional Chinese Medicine, Lichuan, China
  • 3The People's Hospital of Lichuan City, Lichuan, China
  • 4The Third People's Hospital of Yichang, Yichang, China

The final, formatted version of the article will be published soon.

Myocardial ischemia-reperfusion injury denotes the pathological damage resulting from the restoration of blood flow and oxygen supply following acute coronary artery occlusion. Myocardial ischemia-reperfusion injury is commonly seen in acute coronary syndromes and is an important factor in the development of ischemic cardiomyopathy, which severely affects the prognosis of coronary heart disease. The gut microbiota, a complex ecosystem with multifaceted functions, plays a crucial role in host health. Dysregulation of the gut microbiota exerts substantial effects on the onset and progression of cardiovascular diseases, including myocardial ischemia-reperfusion injury. This review elucidates the mechanisms underlying myocardial ischemia-reperfusion injury and the involvement of the gut microbiota in this process, encompassing aspects such as intestinal barrier integrity, microbial dysbiosis, inflammatory responses, oxidative stress, mitochondrial dysfunction, and metabolic alterations. Additionally, we investigate various interventions that modulate myocardial ischemia-reperfusion injury by influencing the gut microbiota. Maintaining a healthy intestinal barrier and a stable microbial ecology is paramount in preventing myocardial ischemia-reperfusion injury. High-fiber diets, probiotic consumption, short-chain fatty acids supplementation, and Traditional Chinese Medicine, can safeguard the heart against myocardial ischemia-reperfusion injury by regulating gut microbiota through diverse mechanisms. As the role of gut microbiota in myocardial ischemia-reperfusion injury continues to be investigated, it provides important therapeutic targets and drug development opportunities for the prevention and treatment of myocardial ischemia-reperfusion injury. However, further in-depth and comprehensive studies are required to fully realize these potentials.

Keywords: Gut Microbiota, Myocardial Ischemia, Reperfusion Injury, Inflammation, gut metabolites

Received: 09 May 2025; Accepted: 02 Sep 2025.

Copyright: © 2025 Chen, Zou, Zhou, Peng and Huang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Chan Peng, The Third People's Hospital of Yichang, Yichang, China
Rui Huang, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.